BioWorld-International-2004-05-12
Arpida Raises CHF51.3M, Plans To Move Iclaprim Into Phase III
Arpida Raises CHF51.3M, Plans To Move Iclaprim Into Phase III
Arpida Ltd. raised CHF51.3 million (US$39.4 million) in a Series C funding round, bringing its total funding to date to CHF105 million. (BioWorld International)

